A new bill that would clarify existing gaps in the Internal Revenue Service's rules governing employer contributions to employee benefit plans may soon be under discussion in the U.S. House of Representatives.

While 75% of employers believe they are doing enough to help manage medical costs, only 46% of employees agree.

Most respondents (84%) expect business impacts from policy or regulatory changes relating to AI use in the workplace over the next 12 months.

More than three-quarters (76%) of surveyed organizations have a Chief AI Officer (CAIO) in 2026, up from just 26% in 2025.

Underscoring these concerns, nearly half of insured adults (46%) say that lowering out-of-pocket costs is the change they'd most like to see to their health insurance.

Regeneron will provide Otarmeni — a new gene therapy for an ultra-rare form of genetic hearing loss recently approved by the U.S. Food and Drug Administration — for free under a new agreement with the U.S. government.

CenterWell Pharmacy (a part of Humana Inc.) announced plans to develop end-to-end employer prescription solutions with Cost Plus Drugs.

The new program seeks to connect GLP-1 management with primary care and Amazon Pharmacy in one place, according to the company.